These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 12702539)

  • 1. Prevention of irinotecan plus 5-fluorouracil/leucovorin-induced diarrhoea by oral administration of neomycin plus bacitracin in first-line treatment of advanced colorectal cancer.
    Alimonti A; Satta F; Pavese I; Burattini E; Zoffoli V; Vecchione A
    Ann Oncol; 2003 May; 14(5):805-6. PubMed ID: 12702539
    [No Abstract]   [Full Text] [Related]  

  • 2. [Irinotecan plus fluorouracil and leucovorin for advanced colorectal cancer].
    Motomura S
    Nihon Rinsho; 2003 Sep; 61 Suppl 7():360-3. PubMed ID: 14574913
    [No Abstract]   [Full Text] [Related]  

  • 3. Efficacy and safety of an irinotecan plus bolus 5-fluorouracil and L-leucovorin regimen for metastatic colorectal cancer in Japanese patients: experience in a single institution in Japan.
    Yoshino T; Boku N; Onozawa Y; Hironaka S; Fukutomi A; Yamaguchi Y; Hasuike N; Yamazaki K; Machida N; Ono H
    Jpn J Clin Oncol; 2007 Sep; 37(9):686-91. PubMed ID: 17720736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of bevacizumab-based combination regimens in patients with previously untreated metastatic colorectal cancer: final results from a randomised phase II study of bevacizumab plus 5-fluorouracil, leucovorin plus irinotecan versus bevacizumab plus capecitabine plus irinotecan (FNCLCC ACCORD 13/0503 study).
    Ducreux M; Adenis A; Pignon JP; François E; Chauffert B; Ichanté JL; Boucher E; Ychou M; Pierga JY; Montoto-Grillot C; Conroy T
    Eur J Cancer; 2013 Apr; 49(6):1236-45. PubMed ID: 23352604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modified XELIRI (capecitabine plus irinotecan) versus FOLFIRI (leucovorin, fluorouracil, and irinotecan), both either with or without bevacizumab, as second-line therapy for metastatic colorectal cancer (AXEPT): a multicentre, open-label, randomised, non-inferiority, phase 3 trial.
    Xu RH; Muro K; Morita S; Iwasa S; Han SW; Wang W; Kotaka M; Nakamura M; Ahn JB; Deng YH; Kato T; Cho SH; Ba Y; Matsuoka H; Lee KW; Zhang T; Yamada Y; Sakamoto J; Park YS; Kim TW
    Lancet Oncol; 2018 May; 19(5):660-671. PubMed ID: 29555258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer.
    Pestalozzi BC
    N Engl J Med; 2001 Jan; 344(4):306; author reply 306-7. PubMed ID: 11191662
    [No Abstract]   [Full Text] [Related]  

  • 7. Neomycin as secondary prophylaxis for irinotecan-induced diarrhea.
    Schmittel A; Jahnke K; Thiel E; Keilholz U
    Ann Oncol; 2004 Aug; 15(8):1296. PubMed ID: 15277273
    [No Abstract]   [Full Text] [Related]  

  • 8. Mortality associated with irinotecan plus bolus fluorouracil/leucovorin.
    Bleiberg H; Di Leo A
    J Clin Oncol; 2002 Feb; 20(4):1145-6. PubMed ID: 11844840
    [No Abstract]   [Full Text] [Related]  

  • 9. [Safety and efficacy of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) in Chinese patients with advanced colorectal cancer].
    Song Y; Li WW; Huang J
    Zhonghua Zhong Liu Za Zhi; 2017 May; 39(5):380-383. PubMed ID: 28535657
    [No Abstract]   [Full Text] [Related]  

  • 10. Irinotecan and 5-FU/ leucovorin in metastatic colorectal cancer: balancing efficacy, toxicity, and logistics.
    Hwang JJ
    Oncology (Williston Park); 2004 Dec; 18(14 Suppl 14):26-34. PubMed ID: 15685831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and tolerability of oxaliplatin plus irinotecan 5-fluouracil and leucovorin regimen in advanced stage colorectal cancer patients pretreated with irinotecan 5-fluouracil and leucovorin.
    Stathopoulos GP; Rigatos SK; Stathopoulos JG; Xynotroulas JP; Dimou E
    Am J Clin Oncol; 2005 Dec; 28(6):565-9. PubMed ID: 16317265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Irinotecan plus S-1 (IRIS) versus fluorouracil and folinic acid plus irinotecan (FOLFIRI) as second-line chemotherapy for metastatic colorectal cancer: a randomised phase 2/3 non-inferiority study (FIRIS study).
    Muro K; Boku N; Shimada Y; Tsuji A; Sameshima S; Baba H; Satoh T; Denda T; Ina K; Nishina T; Yamaguchi K; Takiuchi H; Esaki T; Tokunaga S; Kuwano H; Komatsu Y; Watanabe M; Hyodo I; Morita S; Sugihara K
    Lancet Oncol; 2010 Sep; 11(9):853-60. PubMed ID: 20708966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Application and recent research progress of irinotecan in treatment of advanced colorectal cancer].
    Guan ZZ
    Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):718-9. PubMed ID: 17274384
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluation of adjuvant chemotherapy irinotecan + 5-fluorouracil + leucovorine in advanced colorectal cancer.
    Kulig J; Popiela T; Richter P; Klek S
    Acta Chir Belg; 2007 Jun; 107(3):297-301. PubMed ID: 17685257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer.
    Erlichman C; Goldberg RM; O'Connell MJ
    N Engl J Med; 2001 Jan; 344(4):305; author reply 306-7. PubMed ID: 11191661
    [No Abstract]   [Full Text] [Related]  

  • 16. Fluorouracil, leucovorin and irinotecan associated with aflibercept can induce microscopic colitis in metastatic colorectal cancer patients.
    Ghiringhelli F; Vincent J; Beltjens F; Bengrine L; Ladoire S
    Invest New Drugs; 2015 Dec; 33(6):1263-6. PubMed ID: 26490656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxaliplatin plus irinotecan and leucovorin-modulated 5-fluorouracil triplet regimen every other week: a dose-finding study in patients with advanced gastrointestinal malignancies.
    Comella P; Casaretti R; De Rosa V; Avallone A; Izzo F; Fiore F; Lapenta L; Comella G
    Ann Oncol; 2002 Dec; 13(12):1874-81. PubMed ID: 12453855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase II trial of irinotecan, 5-fluorouracil and leucovorin combined with celecoxib and glutamine as first-line therapy for advanced colorectal cancer.
    Pan CX; Loehrer P; Seitz D; Helft P; Juliar B; Ansari R; Pletcher W; Vinson J; Cheng L; Sweeney C
    Oncology; 2005; 69(1):63-70. PubMed ID: 16088234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toxicity of irinotecan in patients with colorectal cancer.
    Van Cutsem E; Douillard JY; Köhne CH
    N Engl J Med; 2001 Nov; 345(18):1351-2. PubMed ID: 11794165
    [No Abstract]   [Full Text] [Related]  

  • 20. Oxaliplatin plus hydroxycamptothecine versus oxaliplatin plus 5-fluorouracil and leucovorin in treatment of advanced colorectal cancer.
    Yao Y; Sun YJ; Zhao H; Guo YW; Lin F; Cai X; Tang XC; Tang LN; Zhang W
    Chin Med J (Engl); 2006 Nov; 119(21):1829-33. PubMed ID: 17097039
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.